Anika Therapeutics (ANIK) Misses Q4 EPS by 10c
Tweet
Share
E-mailGet Alerts ANIK Hot Sheet
Price: $15.40 +1.45%
EPS Growth %: +115.4%
Financial Fact:
Interest income (expense), net: 93K
Today's EPS Names:
PKE, LNN, More
EPS Growth %: +115.4%
Financial Fact:
Interest income (expense), net: 93K
Today's EPS Names:
PKE, LNN, More
Join SI Premium – FREE
Anika Therapeutics (NASDAQ: ANIK) reported Q4 EPS of ($0.34), $0.10 worse than the analyst estimate of ($0.24). Revenue for the quarter came in at $39.62 million versus the consensus estimate of $37.71 million.
For earnings history and earnings-related data on Anika Therapeutics (ANIK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Exclusive: Moomoo to launch unified ’Moomoo Engine’ trading toolkit
- Prabhudas Lilladher Starts Blue Star Limited (BLSTR:IN) at Buy (1)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
